Bionano Genomics, Inc. Common Stock
$1.73
-$0.01 (-0.57%)
$1.69Day Range$1.87
Key Statistics
Market Cap
$20.37M
Shares Outstanding
11.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 1, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$1.75
Day High
$1.87
Day Low
$1.69
Volume
1.20M
VWAP
$1.76
Prev Close
$1.74
Transactions
--
Acc. Volume
--
About Bionano Genomics, Inc. Common Stock
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
LABORATORY ANALYTICAL INSTRUMENTSSIC 382697 employees9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA, 92121(858) 888-7600IPO Aug 1, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001411690
- Composite FIGI
- BBG001KWWRS9
- Share Class FIGI
- BBG001V0SSM6
- Ticker Root
- BNGO
- SIC Code
- 3826
About Bionano Genomics, Inc. Common Stock (BNGO) Stock
Bionano Genomics, Inc. Common Stock (BNGO) closed the 2026-09-18 session at $1.73, down 0.57% versus the previous close (-0.01). The stock opened at $1.75 and traded between $1.69 and $1.87 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $1.76.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Bionano Genomics, Inc. Common Stock has a market capitalization of $20.4 million. The company operates in the LABORATORY ANALYTICAL INSTRUMENTS industry classification. BNGO is listed on the XNAS exchange. The company employs approximately 97 people. Bionano Genomics, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2018-08-01.
On this page you can find market BNGO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the LABORATORY ANALYTICAL INSTRUMENTS sector.